Related Experiment Video
Updated: May 2, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
MicroRNAs and cholestatic liver diseases
Jose J G Marin1, Luis Bujanda, Jesus M Banales
1aExperimental Hepatology and Drug Targeting (HEVEFARM), Biomedical Research Institute of Salamanca (IBSAL), University of Salamanca, Salamanca bCenter for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid cDepartment of Liver and Gastrointestinal Diseases, Biodonostia Research Institute - Donostia University Hospital, University of Basque Country (UPV/EHU), San Sebastián dIKERBASQUE, Basque Foundation for Science and 'Asociación Española Contra el Cáncer, (AECC)', Spain.
MicroRNAs (miRNAs) are increasingly recognized for their role in cholestatic liver diseases, influencing bile acid balance and disease progression. These molecules show potential as diagnostic biomarkers and therapeutic targets for liver conditions.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Cholestatic liver disorders are characterized by impaired bile flow.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- Emerging evidence implicates miRNAs in the pathogenesis of liver diseases.
Purpose of the Study:
- To review the current evidence on the role of miRNAs in cholestatic liver diseases.
- To discuss the involvement of miRNAs in liver secretory function under physiological and pathological conditions.
Main Methods:
- Literature review of recent studies on miRNAs and cholestasis.
- Analysis of miRNA expression data in cholestatic liver disease patients.
- Discussion of miRNA regulatory mechanisms in liver pathophysiology.
Main Results:
- miRNAs are crucial for bile acid homeostasis and modulate cholestasis-related processes like proliferation, apoptosis, fibrosis, and cancer.
- Altered miRNA expression is observed in serum, blood cells, and liver tissue of patients with chronic cholestatic liver diseases, including primary biliary cirrhosis.
- Specific miRNAs are implicated in the pathogenesis and progression of cholestatic liver disorders.
Conclusions:
- While understanding is evolving, miRNAs play a significant role in cholestatic liver diseases.
- miRNAs show promise as biomarkers for diagnosing and monitoring cholestatic liver conditions.
- miRNAs may offer novel therapeutic strategies for treating cholestatic liver diseases.
More Related Videos
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis I: Introduction
Cholecystitis
Fungal Phylum Microsporidia
Chronic Pancreatitis II: Pathophysiology
MicroRNAs

